Lurasidone metabolite 14326 is primarily studied in the context of pharmacokinetics and drug metabolism research. It plays a significant role in understanding how the parent drug, Lurasidone, is processed and broken down in the body. Researchers analyze this metabolite to evaluate its pharmacological activity, potential side effects, and overall contribution to the therapeutic efficacy of Lurasidone. This information is crucial for optimizing dosing regimens and ensuring patient safety, particularly in the treatment of psychiatric conditions such as schizophrenia and bipolar depression. Additionally, studying this metabolite aids in identifying drug-drug interactions and assessing the impact of genetic variations on drug metabolism.